Chartreusin
Chartreusin is an antibiotic that is active against certain Gram-positive organisms and mycobacteria. Chartreusin is also active against the Micrococcus fiyogenes v. aureus phage[1].
Product Specifications
CAS Number
6377-18-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/chartreusin.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C=CC=C2O[C@H]3[C@@H]([C@H]([C@@H](O)[C@@H](C)O3)O)O[C@]4([H])[C@@H]([C@H]([C@@H](O)[C@@H](C)O4)OC)O)C2=C5C(C6=C(O7)C=CC(C)=C6C(O5)=O)=C1C7=O
Molecular Formula
C32H32O14
Molecular Weight
640.59
Precautions
H302, H315, H319, H335
References & Citations
[1]Leach B E, et al. Chartreusin, a new antibiotic produced by Streptomyces chartreusis, a new species. Journal of the American Chemical Society, 1953, 75 (16) : 4011-4012.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1281645-01 0.5 mg (E-Coli)
Recombinant Rat Long-chain-fatty-acid--CoA ligase 3 (Acsl3), partial
Sign In for Pricing
View Details MBS1281645-02 0.05 mg (Baculovirus)
Recombinant Rat Long-chain-fatty-acid--CoA ligase 3 (Acsl3), partial
Sign In for Pricing
View Details MBS1281645-03 0.5 mg (Yeast)
Recombinant Rat Long-chain-fatty-acid--CoA ligase 3 (Acsl3), partial
Sign In for Pricing
View Details MBS1281645-04 0.05 mg (Mammalian-Cell)
Recombinant Rat Long-chain-fatty-acid--CoA ligase 3 (Acsl3), partial
Sign In for Pricing
View Details